The announcement from Moderna (MRNA 51.39, +2.44, +5.0%) that the FDA has allowed the company to proceed to a Phase 2 trial for its COVID-19 vaccine candidate. In addition Gildan Science has had its drug clear for treatment by the fda
1 Like